Filing Details
- Accession Number:
- 0000950170-24-131568
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-27 16:48:21
- Reporting Period:
- 2024-11-25
- Accepted Time:
- 2024-11-27 16:48:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1861560 | Nuvalent Inc. | NUVL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1862123 | Matthew Shair | C/O Nuvalent, Inc. One Broadway, 14Th Floor Cambridge MA 02142 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2024-11-25 | 978 | $95.71 | 223,544 | No | 4 | S | Indirect | See Footnote |
| Class A Common Stock | Disposition | 2024-11-25 | 992 | $96.69 | 222,552 | No | 4 | S | Indirect | See Footnote |
| Class A Common Stock | Disposition | 2024-11-25 | 30 | $97.40 | 222,522 | No | 4 | S | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Footnote |
| No | 4 | S | Indirect | See Footnote |
| No | 4 | S | Indirect | See Footnote |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Class A Common Stock | 1,427,197 | Direct |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2023.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.18 to $96.17, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) of this Form 4.
- These shares are held by Matthew D. Shair 2021 Irrevocable Family Trust. The reporting person has voting and dispositive power over the shares beneficially owned by Matthew D. Shair 2021 Irrevocable Family Trust.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.19 to $97.10, inclusive.
Billionaire Hedge Funds
